Search results
Order by most recent / most popular / relevance
Results: 11-20 of 57
Do DNA patents affect genetic sequencing and testing advances?
- Shook Hardy & Bacon LLP
- -
- USA
- -
- November 15 2012
University of Missouri-Kansas City School of Law Professor Christopher Holman writes in the most recent issue of Nature Technology that while DNA sequencing technology has spawned a myriad of patent-related lawsuits, “aggressive patent acquisition and enforcement practices” show no signs of abating and may not necessarily be hindering the development of next-generation DNA sequencing and analysis technologies
NGOs request march-in rights for patented drug
- Shook Hardy & Bacon LLP
- -
- USA
- -
- November 1 2012
Four non-governmental organizations (NGOs) have filed a petition with the National Institutes of Health (NIH) requesting that it grant march-in rights under the Bayh-Dole Act for a patented drug that they claim is “a federally funded invention that is much more expensive in the United States than in Canada, Europe or other high-income countries.”
Federal Circuit’s patent infringement ruling conflicts with USPTO re-examination on validity
- Shook Hardy & Bacon LLP
- -
- USA
- -
- November 1 2012
The Federal Circuit Court of Appeals has denied a request for an en banc rehearing by a medical-device patent holder which argued that the U.S. Patent and Trademark Office’s (USPTO’s) Board of Patent Appeals had effectively nullified a previous Federal Circuit decision on the validity of its patent
News bytes
- Shook Hardy & Bacon LLP
- -
- USA
- -
- October 18 2012
The U.S. Patent and Trademark Office reopens the comment period on its proposed rulemaking and proposed examination guidelines, published on July 26, 2012, “to implement the first-inventor-to-file provisions of the Leahy-Smith America Invents Act.” Comments may now be submitted until November 5
News bytes
- Shook Hardy & Bacon LLP
- -
- USA
- -
- October 3 2012
U.S. Health and Human Services Secretary Kathleen Sebelius delegates authority to the Food and Drug Administration (FDA) to determine whether clinical trial information was not submitted to the Clinical Trial Registry and Results Data Bank as required by law or “was submitted but is false or misleading in any particular.”
Moody’s claims “the worst is over” for pharmaceutical companies facing patent cliff
- Shook Hardy & Bacon LLP
- -
- USA
- -
- October 3 2012
Moody’s Investor Services has reportedly revised its outlook for the global pharmaceutical industry and upgraded it to stable, apparently anticipating that earnings will rebound in 2013 with the slowdown in patent expirations, characterized by many industry observers as the “patent cliff.”
ACLU weighs in on patentability of human genes in Myriad Genetics
- Shook Hardy & Bacon LLP
- -
- USA
- -
- October 3 2012
American Civil Liberties Union (ACLU) attorneys representing the petitioners in The Association for Molecular Pathology v. Myriad Genetics, Inc., No. 12-398 (U.S., docketed October 1, 2012), have filed their petition for review before the U.S. Supreme Court. Information about the Federal Circuit Court of Appeals ruling from which the petition has been filed appears in Issue 41 of this Bulletin
Study shows rise in biotech patent litigation
- Shook Hardy & Bacon LLP
- -
- USA
- -
- September 20 2012
PricewaterhouseCoopers LLP has released its “2012 Patent Litigation Study,” which shows that the 4,105 patent lawsuits filed in 2011 marked a high point and a 22-percent increase from the previous year
Fractured Myriad Genetics ruling follows SCOTUS remand
- Shook Hardy & Bacon LLP
- -
- USA
- -
- August 30 2012
Ruling that one plaintiff had standing to seek a declaratory judgment as to the patent eligibility of certain genetic discoveries, the Federal Circuit Court of Appeals has once again reversed in part and affirmed in part a lower court’s determination that isolated DNA molecules and methods of comparing molecules to determine whether a patient’s genes have mutations that could cause breast and ovarian cancer were not patent eligible
News bytes
- Shook Hardy & Bacon LLP
- -
- USA
- -
- August 30 2012
The U.S. Patent and Trademark Office (USPTO) schedules a September 6, 2012, roundtable “to obtain public input from organizations and individuals on issues relating to the USPTO’s proposed implementation of the first-inventorto- file provisions of the America Invents Act.”
Current Search
- Jurisdiction - USA
- Author - Madeleine McDonough
- Author - Chris A. Johnson
- Workarea - Healthcare
- Workarea - Patents